Pandora, Gap Post R...
Health Care: Drugs
Ampio Pharmaceuticals Inc. (AMPE: NASDAQ)
$5.08 0.39 | 8.32%
05/23/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 50.00K | 18.75K | 0.00 | 0.00 |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 50.00K | 18.75K | 0.00 | 0.00 |
| Selling, General, and Administrative Expenses | 4.38M | 4.50M | 4.73M | 21.87K |
| Research & Development | 7.49M | 6.65M | 1.97M | 0.00 |
| Operating Income before D & A (EBITDA) | -11.82M | -11.13M | -6.70M | -21.87K |
| Depreciation & Amortization | 62.40K | 42.55K | 0.00 | 0.00 |
| Interest Income | 21.94K | 6.68K | 815.00 | 0.00 |
| Other Income - Net | 205.77K | -7.14M | -1.33M | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -11.66M | -18.31M | -8.03M | -21.87K |
| Interest Expense | 0.00 | 8.36K | 19.54K | 4.18K |
| Pre-Tax Income | -11.66M | -18.32M | -8.05M | -26.05K |
| Income Taxes | 0.00 | 82.50K | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -11.59M | -18.36M | -8.05M | -26.05K |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -11.59M | -18.36M | -8.05M | -26.05K |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -11.59M | -18.36M | -8.05M | -26.05K |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-11.59M | -18.36M | -8.05M | -26.05K |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -11.59M | -18.36M | -8.05M | -26.05K |
| Basic EPS from Continuing Ops. | -0.34 | -0.71 | -0.49 | -0.03 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.34 | -0.71 | -0.49 | -0.03 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.34 | -0.71 | -0.49 | -0.03 |
| Basic Normalized Net Income/Share | -0.34 | -0.71 | -0.49 | -0.03 |
| EPS fr Continuing Ops. | -0.34 | -0.71 | -0.49 | -0.03 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.34 | -0.71 | -0.49 | -0.03 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.34 | -0.71 | -0.49 | -0.03 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.34 | -0.71 | -0.49 | -0.03 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with AMPE
- Portfolio NameUser Type
- UserFlying Monkey King's Actuals
- ContributorStocks Under-$10 Setting Up...
- UserFirst Try
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
Latest AMPE Headlines from TheStreet
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Ampio's Eye Drug Trial Design Won't Pass FDA Muster 04.02.13 | 09:04 am
- 5 Stocks Under $10 Set to Soar 09.20.12 | 01:09 pm
- A Biotech Short Seller Responds To Critics 07.17.12 | 08:07 am
- Ampio Insiders, Aided by PR Blitz, Soon Free to Sell Millions of Shares 07.02.12 | 01:07 pm
- Biotech Stock Mailbag: Osiris, Arena, Ampio 06.22.12 | 06:06 am
- Ampio Spins A Tale of Curing Blindness 06.11.12 | 03:06 pm
- Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm 04.05.12 | 05:04 am
- 6 Stocks Under $10 Moving Higher 12.14.11 | 01:12 pm
Press Releases for AMPE
- Ampio Pharmaceuticals Announces Participation At The UBS Global Healthcare Conference - PR Newswire 05.13.13 | 08:05 am
- Ampio Pharmaceuticals Completes Enrollment In Run-In SPRING Study Of Ampion In Osteoarthritis Of The Knee - PR Newswire 04.25.13 | 08:04 am
- Ampio Receives FDA Clearance To Initiate Clinical Trial Of Ampionâ¿¢ For The Treatment Of Osteoarthritis Of The Knee: Patient Treatments Have Begun. - PR Newswire 04.02.13 | 04:04 am
- Ampio Receives FDA Acceptance Of Its Patient Outcome For Premature Ejaculation (POPE) Questionnaire, Paving The Way For Its US Pivotal Trial On Zertaneâ¿¢ - PR Newswire 03.11.13 | 04:03 am
- Ampio Pharmaceuticals Initiates Clinical Trial Of Optinaâ¿¢ In Diabetic Macular Edema (DME): First Patient Dosed - PR Newswire 02.27.13 | 04:02 am
- Ampio Pharmaceuticals Modifies Ampionâ¿¢ IND For Osteoarthritis Of The Knee To Include A Dose Escalation Run-In Study And Prepares To Launch Pivotal Clinical Trial - PR Newswire 02.25.13 | 04:02 am
- Ampio Forms Luoxis Diagnostics To Commercialize ORP Technology - PR Newswire 02.11.13 | 04:02 am
- Ampio Pharmaceuticals Announces Participation At Upcoming Investor Conference - PR Newswire 01.22.13 | 04:01 am
- Ampio Pharmaceuticals Announces Active IND For Optinaâ¿¢ For The Treatment Of Diabetic Macular Edema (DME) - PR Newswire 01.22.13 | 04:01 am
- Ampio Pharmaceuticals, Inc. (AMPE) Announces Appointment Of Josh Disbrow As Chief Operating Officer Effective December 15, 2012 - PR Newswire 11.28.12 | 04:11 am
Partner Headlines for AMPE
- Ampio Pharma Initiates Phase III, Investors Extend Momentum - Seeking Alpha 05.03.13 | 09:05 am
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climb - Investor's Business Daily 04.02.13 | 12:04 pm
- BioPharma Stock Movers For Wednesday, August 29 - Seeking Alpha 08.29.12 | 09:08 am
- Ultimate Market Recap: Barclays Chairman Bows Out, ATPG Looking Slick - Wall St. Cheat Sheet 07.02.12 | 10:07 am
- Morning Market Movers - Benzinga 07.02.12 | 09:07 am
- Arena Pharma FADES Below $10 and 4 High Demand Stocks ATTRACTING Eyes - Wall St. Cheat Sheet 07.02.12 | 02:07 am
- Weekly Market Wrap: Stocks RALLY, Gold SPARKLES, Apple's New Products REVEALED - Wall St. Cheat Sheet 06.17.12 | 12:06 pm
- Company News for June 12, 2012 - Corporate Summary - Zacks 06.12.12 | 10:06 am
- These 5 Small Cap Stocks Are Up Better Than 10% Today - Benzinga 06.11.12 | 01:06 pm
- 4 Contrarian Stock Climbers in Trading Action as Centene Falls Hard - Wall St. Cheat Sheet 06.11.12 | 01:06 pm
